J&J's latest recall: moldy Risperdal Consta

Janssen Pharmaceuticals (Johnson & Johnson) has issued a voluntary US recall of one lot of Risperdal Consta (risperidone) after mold was found in a sample during a routine test. This is the latest in a string of J&J recalls over the last several years.

Janssen Pharmaceuticals (Johnson & Johnson) has issued a voluntary US recall of one lot of Risperdal Consta (risperidone) after mold was found in a sample during a routine test. This is the latest in a string of J&J recalls over the last several years.

Risperdal Consta, which is produced by external manufacturer Alkermes, is a long-acting injection administered every two weeks by a healthcare...

More from Anti-infective

In Brief: Gilead HIV Trials On Hold Over Safety Signal

 

The FDA has paused Gilead’s HIV trials of GS-1720 and GS-4182 over safety concerns. The company’s upcoming PrEP PDUFA looks to be unaffected.

In Brief: PolyPid’s D-PLEX100 Aces Phase III Trial, US Partner, Submission Eyed

 

PolyPid's D-PLEX100 meets Phase III endpoints this time around, significantly reducing surgical point infections in abdominal colorectal surgery, and is set for a US approval submission early next year.

With ACIP Upheaval, Merck & Co. Among Those Left In A Lurch

 

Merck’s newly approved Enflonsia for RSV is one of the products that was expected to be recommended for use by the CDC advisory committee in June.

Stock Watch: On Q1 Vaccine Sales And Measles Outbreaks

 
• By 

A recent study suggested that measles could become endemic in the US due to low vaccination rates. However, first-quarter vaccine sales offered a more nuanced picture.

More from Therapy Areas